Korsana Biosciences, Inc.
KRSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001755237
No open-market purchases or sales by Korsana Biosciences, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $11.2M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Korsana Biosciences, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 62 | 1 | 56 | −5 |
| Shares | 24.7M | 867 | 23.7M | −1.03M (−4.2%) |
| Value | $75.8M | $2.00K | $40.7M | −$35.1M (−46.3%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Korsana Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acadian Asset Management LLC | 249,792 | $428.0K | 0.00% |
| Intrinsic Value Partners, LLC | 50,665 | $87.0K | 0.09% |
| Walleye Capital LLC | 25,345 | $44.0K | 0.00% |
| Wolverine Trading, LLC | 17,964 | $29.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 13,922 | $24.0K | 0.00% |
| Davenport & Co LLC | 12,791 | $22.0K | 0.00% |
| Marshall Wace, LLP | 10,446 | $18.0K | 0.00% |
| Simplex Trading, LLC | 6,540 | $11.0K | 0.00% |
| Spire Wealth Management | 1,082 | $2.00K | 0.00% |
| CWM, LLC | 297 | $1.00K | 0.00% |
| High Net Worth Advisory Group LLC | 500 | $1.00K | 0.00% |
| Concord Wealth Partners | 10 | $0 | 0.00% |
| Amplius Wealth Advisors, LLC | 10 | $0 | 0.00% |
Sold out (18)
Institutions that held Korsana Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| EcoR1 Capital, LLC | 1,606,276 | $4.93M |
| Jacobs Levy Equity Management, Inc | 91,285 | $280.0K |
| Virtu Financial LLC | 55,301 | $170.0K |
| Jump Financial, LLC | 52,000 | $160.0K |
| Goldman Sachs Group Inc | 43,903 | $135.0K |
| JPMorgan Chase & Co | 41,333 | $127.0K |
| Broderick Brian C | 32,175 | $99.0K |
| PDT Partners, LLC | 30,100 | $92.0K |
| ExodusPoint Capital Management, LP | 22,701 | $70.0K |
| Jane Street Group, LLC | 16,607 | $51.0K |
| XTX Topco Ltd | 10,383 | $32.0K |
| UBS Group AG | 3,544 | $11.0K |
| Barclays PLC | 2,302 | $7.00K |
| Gerber Kawasaki Wealth & Investment Management | 2,046 | $6.00K |
| Total Clarity Wealth Management, Inc. | 1,500 | $5.00K |
| O'Shaughnessy Asset Management, LLC | 1 | $0 |
| Cutler Group LP | 200 | $0 |
| Belvedere Trading LLC | 156 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held Korsana Biosciences, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Berman Capital Advisors, LLC | 867 | $2.00K |